A new study identifies a mechanism for how COVID vaccines may, in infrequent cases, drive heart inflammation, a condition ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...

We asked experts about how the technology works, its safety and its potential in medicine. By Nina Agrawal Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA vaccines ...

Young and middle-age adults who had at least one dose of a COVID-19 mRNA vaccine were less likely to die of any cause in the ...

A joint research team led by Professor V. Narry Kim (Director of the Center for RNA Research, Institute for Basic Science) and Professor Jong-Seo Kim of the School of Biological Sciences at Seoul ...

mRNA vaccines tell the body how to make a protein that produces immunity against specific microbes. In contrast, traditional vaccines use weakened or dead microbes, or pieces of them, to stimulate ...

Washington University in St. Louis student Julian McCall receives a dose of Pfizer's mRNA-based COVID-19 vaccine. A new study by researchers at Washington University School of Medicine in St. Louis ...

WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...

The United States may be losing its edge in mRNA technology­­. The technology, which powered life-saving COVID-19 vaccines and is now rocketing new cancer therapeutics forward, will soon undergo a ...